IL-13Rα2 is one of the most widely studied tumor-associated antigens in glioma research, which is also overexpressed in a variety of solid cancers, including gliomas, melanoma and pancreatic, ovarian, breast, colon and prostate cancers [17, 18]. Here, IL13RA2 is linked to glioma.